The One Fund Boston, MGH and Massachusetts Eye and Ear Infirmary are creating the One Fund Center, a collaboration that will offer ongoing care to those affected by the often invisible, yet persistent, injuries sustained in the Boston Marathon bombings.. Read more.
9/24/14: Crizotinib treatment effective against ROS1-positive lung cancer Treatment with the targeted therapy drug crizotinib shown to effectively halt the growth of lung tumors driven by rearrangements of the ROS1 gene in MGH-led clinical trial.
9/26/14: Policies of NIH, other funders, have improved data-sharing by life-science investigators Policies put into place by major funding agencies like the National Institutes of Health, and to a lesser extent by scientific journals, appear to be meeting the goal of increasing the sharing of scientific resources among life science investigators.
9/22/14: Mass. General study reveals gene expression patterns in pancreatic circulating tumor cells Analysis of circulating tumor cells in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.
9/16/14: Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas A study by MGH investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine point-of-care CD4 testing at the time of HIV diagnosis could be cost effective in countries where health care and other resources are severely limited.
9/03/14: Digital mammography system developed at Mass. General Hospital receives FDA approval A digital mammography system developed based on concepts originally tested at MGH has been approved by the U.S. Food and Drug Administration.
9/03/14: One Fund Center launches in September to offer ongoing care for those affected by the marathon bombings The One Fund Boston, MGH and Massachusetts Eye and Ear Infirmary today announced the creation of the One Fund Center, a collaboration that will offer ongoing care to those affected by the often invisible, yet persistent, injuries sustained in the Boston Marathon bombings.
Newsletters & Publications
Hotline Each week, MGH Hotline reports important news within the Massachusetts General Hospital community featuring employees and initiatives that focus on bettering the future of clinical care, research and training.
Proto Proto, a magazine that reaches 75,000 thought leaders nationwide, stakes its ground on medicine's leading edge, reporting back from the frontiers of research and practice—exploring breakthroughs, dissecting controversies and opening a forum for informed debate.
Mass General Magazine Mass General Magazine takes you into the heart of the institution, describing ways in which Mass General is leading the way in educating physicians, nurses and other healthcare professionals; in improving the health of local and distant communities; and in establishing best practices and health policy.
09/15/2014: Two hospitals team up to aid domestic violence victims
The Boston Globe
article about partnership between MGH and Mass. Eye and Ear Infirmary
09/15/2014: Study finds half of U.S. adults at risk for health problems related to elevated blood sugar
report featuring MGH physician David Nathan
09/15/2014: After traumatic brain injury, a young man’s astounding recovery
feature on patient treated at MGH, quotes physician Brian Edlow
09/15/2014: Royal siblings: What's the ideal age gap between children?
quotes MGH physician Allison Bryant
09/15/2014: Diabetes’ genetic variety
article on the work of MGH investigator Amit Majithia
09/15/2014: U.S. government set to announce surge of help for Ebola epidemic
quotes MGH physician Michael Callahan
09/15/2014: Generic Drugs Beat Brand-Names for Patient Adherence, Cost, Outcomes
quotes MGH physician Jason Wasfy